𝔖 Bobbio Scriptorium
✦   LIBER   ✦

On the Use of Cavinton and Cerebrolysin in the Preventive Treatment of Alzheimer’s Disease1

✍ Scribed by D. S. Kasatkin

Publisher
Springer US
Year
2011
Tongue
English
Weight
84 KB
Volume
42
Category
Article
ISSN
0097-0549

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Medicinal chemistry approaches for the t
Medicinal chemistry approaches for the treatment and prevention of Alzheimer's disease
✍ S.O. Bachurin 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 409 KB

## Abstract Alzheimer's disease (AD) is the most common form of dementia, which is characterised by progressive deterioration of memory and higher cortical functions that ultimately result in total degradation of intellectual and mental activities. Modern strategies in the search of new therapeutic

Use of vitamin C and E in the treatment
Use of vitamin C and E in the treatment of Alzheimer's disease
✍ Sönke Arlt; Tomas Müller-Thomsen; Ulrike Beisiegel 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB 👁 1 views

## Abstract Since it has become evident that increased oxidative stress is involved in the pathogenesis of Alzheimer's disease, the therapeutical use of antioxidants has been discussed. To date there are several studies showing that lipid peroxidation in particular is increased not only in brain ti

Tetrahydroaminoacridine and lecithin in
Tetrahydroaminoacridine and lecithin in the treatment of Alzheimer's disease
✍ Henry C. Weinstein; Saskia Teunisse; Willem A. Gool 📂 Article 📅 1991 🏛 Springer 🌐 English ⚖ 529 KB

In 12 ambulant patients with a clinical diagnosis of probable Alzheimer's disease, a 12-week, double-blind, placebo-controlled study with 100 mg/day tetrahydroaminoacridine (THA) and 10 g/day lecithin is reported. The aim of the study was to find whether treatment would result in an improvement of c